A ‘natural Botox’ product is being created by a Scottish start-up firm in a multi-million pound deal with a European medical device manufacturer.
Burdica Biomed is part of the Edinburgh Pre-Incubator Scheme and will provide the base material for an injectable gel filler that can be used for lip enhancement and wrinkle reduction.
The product should complete registration next year and will allow the firm to break into the $750million global market for ‘dermal fillers’.
Burdica’s material is based on hyaluronic acid (HA), a substance that occurs naturally in the body and claims its product will be manufactured to make its effect on users longer-lasting and its dosage more controllable.
The product, which has not yet been trademarked, will firstly be distributed in Europe through a number of channels, likely to include doctors and dentists.
Burdica launched in October 2007 and aims to be profitable within 18 months.